Advertisement
Screener

DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options, 2007

DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2007-06-13: Reporting owner Plotkin Stanley A; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2007-06-13: Reporting owner Phillips Peggy V; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2007-06-13: Reporting owner LAWRENCE DAVID M; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2007-06-13: Reporting owner GILBERT DENISE; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2007-06-13Plotkin Stanley A
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$4.66
exercise price
2007-06-15
2007-06-13Phillips Peggy V
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,500
7,500 owned after
$4.66
exercise price
2007-06-15
2007-06-13LAWRENCE DAVID M
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$4.66
exercise price
2007-06-15
2007-06-13GILBERT DENISE
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$4.66
exercise price
2007-06-15
2007-06-13CARSON DENNIS
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$4.66
exercise price
2007-06-15
2007-06-13Buc Nancy L
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$4.66
exercise price
2007-06-15
2007-06-13ORONSKY ARNOLD L
Director
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$4.66
exercise price
2007-06-15
2007-02-02VAN NEST GARY A
Officer (VP, Preclinical Research)
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+25,000
25,000 owned after
$6.19
exercise price
2007-02-06
2007-02-02SMELTZER DEBORAH A
Officer (VP Operations and CFO)
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+60,000
60,000 owned after
$6.19
exercise price
2007-02-06
2007-02-02COFFMAN ROBERT
Officer (Chief Scientific Officer & VP)
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+40,000
40,000 owned after
$6.19
exercise price
2007-02-06
2007-02-02TUCK STEPHEN F
Officer (VP Biopharmaceutical Developmt)
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
50,000 owned after
$6.19
exercise price
2007-02-06
2007-02-02HENN TIMOTHY G
Officer (VP, Finance & Administration)
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+20,000
20,000 owned after
$6.19
exercise price
2007-02-06
2007-02-02DINA DINO
Director, Officer (President, CEO and Director)
4Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+250,000
250,000 owned after
$6.19
exercise price
2007-02-06